• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.
Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients.
Further information
Medical Disclaimer
The content of Holevn is solely for the purpose of providing information about Thuốc Edrophonium and Atropine and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Please contact your nearest doctor or clinic, hospital for advice. We do not accept liability if the patient arbitrarily uses the drug without following a doctor’s prescription.
Reference from: https://www.drugs.com/ppa/edrophonium-and-atropine.html
• Atropine: Patients who are bradycardic or at risk of being bradycardic (eg, those on a beta-blocker or cardiovascular patients who received anesthesia with an opioid and nitrous oxide only) should first receive atropine prior to edrophonium-atropine combination. Most arrhythmias occur within 2 minutes of administration and reverse shortly thereafter. Atropine should be available for immediate use in case of severe cholinergic reaction. Bradyarrhythmias respond to small doses of atropine.
• Nondepolarizing muscle relaxants: Should not be administered before any nondepolarizing muscle relaxant.
Dosage form specific issues:
• Sodium sulfite: Products may contain sodium sulfite.
Monitoring Parameters
Vital signs, ECG, and ventilatory support; neuromuscular function
Pregnancy Risk Factor
C
Pregnancy Considerations
Animal reproduction studies have not been conducted with this combination. Refer to individual agents.
Patient Education
• Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?)
• Patient may experience dry mouth, nausea, vomiting, diarrhea, abdominal cramps, loss of strength and energy, sweating a lot, or passing a lot of urine. Have patient report immediately to prescriber abnormal heartbeat, difficulty breathing, slow breathing, shallow breathing, severe dizziness, passing out, seizures, difficulty speaking, difficulty swallowing, slow heartbeat, fast heartbeat, or severe injection site redness, burning, or pain (HCAHPS).
• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.
Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients.
Further information
Medical Disclaimer
The content of Holevn is solely for the purpose of providing information about Thuốc Edrophonium and Atropine and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Please contact your nearest doctor or clinic, hospital for advice. We do not accept liability if the patient arbitrarily uses the drug without following a doctor’s prescription.
Reference from: https://www.drugs.com/ppa/edrophonium-and-atropine.html
• Atropine: Patients who are bradycardic or at risk of being bradycardic (eg, those on a beta-blocker or cardiovascular patients who received anesthesia with an opioid and nitrous oxide only) should first receive atropine prior to edrophonium-atropine combination. Most arrhythmias occur within 2 minutes of administration and reverse shortly thereafter. Atropine should be available for immediate use in case of severe cholinergic reaction. Bradyarrhythmias respond to small doses of atropine.
• Nondepolarizing muscle relaxants: Should not be administered before any nondepolarizing muscle relaxant.
Dosage form specific issues:
• Sodium sulfite: Products may contain sodium sulfite.
Monitoring Parameters
Vital signs, ECG, and ventilatory support; neuromuscular function
Pregnancy Risk Factor
C
Pregnancy Considerations
Animal reproduction studies have not been conducted with this combination. Refer to individual agents.
Patient Education
• Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?)
• Patient may experience dry mouth, nausea, vomiting, diarrhea, abdominal cramps, loss of strength and energy, sweating a lot, or passing a lot of urine. Have patient report immediately to prescriber abnormal heartbeat, difficulty breathing, slow breathing, shallow breathing, severe dizziness, passing out, seizures, difficulty speaking, difficulty swallowing, slow heartbeat, fast heartbeat, or severe injection site redness, burning, or pain (HCAHPS).
• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.
Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients.
Further information
Medical Disclaimer
The content of Holevn is solely for the purpose of providing information about Thuốc Edrophonium and Atropine and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Please contact your nearest doctor or clinic, hospital for advice. We do not accept liability if the patient arbitrarily uses the drug without following a doctor’s prescription.
Reference from: https://www.drugs.com/ppa/edrophonium-and-atropine.html
• Atropine: Patients who are bradycardic or at risk of being bradycardic (eg, those on a beta-blocker or cardiovascular patients who received anesthesia with an opioid and nitrous oxide only) should first receive atropine prior to edrophonium-atropine combination. Most arrhythmias occur within 2 minutes of administration and reverse shortly thereafter. Atropine should be available for immediate use in case of severe cholinergic reaction. Bradyarrhythmias respond to small doses of atropine.
• Nondepolarizing muscle relaxants: Should not be administered before any nondepolarizing muscle relaxant.
Dosage form specific issues:
• Sodium sulfite: Products may contain sodium sulfite.
Monitoring Parameters
Vital signs, ECG, and ventilatory support; neuromuscular function
Pregnancy Risk Factor
C
Pregnancy Considerations
Animal reproduction studies have not been conducted with this combination. Refer to individual agents.
Patient Education
• Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?)
• Patient may experience dry mouth, nausea, vomiting, diarrhea, abdominal cramps, loss of strength and energy, sweating a lot, or passing a lot of urine. Have patient report immediately to prescriber abnormal heartbeat, difficulty breathing, slow breathing, shallow breathing, severe dizziness, passing out, seizures, difficulty speaking, difficulty swallowing, slow heartbeat, fast heartbeat, or severe injection site redness, burning, or pain (HCAHPS).
• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.
Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients.
Further information
Medical Disclaimer
The content of Holevn is solely for the purpose of providing information about Thuốc Edrophonium and Atropine and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Please contact your nearest doctor or clinic, hospital for advice. We do not accept liability if the patient arbitrarily uses the drug without following a doctor’s prescription.
Reference from: https://www.drugs.com/ppa/edrophonium-and-atropine.html
• Atropine: Patients who are bradycardic or at risk of being bradycardic (eg, those on a beta-blocker or cardiovascular patients who received anesthesia with an opioid and nitrous oxide only) should first receive atropine prior to edrophonium-atropine combination. Most arrhythmias occur within 2 minutes of administration and reverse shortly thereafter. Atropine should be available for immediate use in case of severe cholinergic reaction. Bradyarrhythmias respond to small doses of atropine.
• Nondepolarizing muscle relaxants: Should not be administered before any nondepolarizing muscle relaxant.
Dosage form specific issues:
• Sodium sulfite: Products may contain sodium sulfite.
Monitoring Parameters
Vital signs, ECG, and ventilatory support; neuromuscular function
Pregnancy Risk Factor
C
Pregnancy Considerations
Animal reproduction studies have not been conducted with this combination. Refer to individual agents.
Patient Education
• Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?)
• Patient may experience dry mouth, nausea, vomiting, diarrhea, abdominal cramps, loss of strength and energy, sweating a lot, or passing a lot of urine. Have patient report immediately to prescriber abnormal heartbeat, difficulty breathing, slow breathing, shallow breathing, severe dizziness, passing out, seizures, difficulty speaking, difficulty swallowing, slow heartbeat, fast heartbeat, or severe injection site redness, burning, or pain (HCAHPS).
• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.
Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients.
Further information
Medical Disclaimer
The content of Holevn is solely for the purpose of providing information about Thuốc Edrophonium and Atropine and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Please contact your nearest doctor or clinic, hospital for advice. We do not accept liability if the patient arbitrarily uses the drug without following a doctor’s prescription.
Reference from: https://www.drugs.com/ppa/edrophonium-and-atropine.html
• Atropine: Patients who are bradycardic or at risk of being bradycardic (eg, those on a beta-blocker or cardiovascular patients who received anesthesia with an opioid and nitrous oxide only) should first receive atropine prior to edrophonium-atropine combination. Most arrhythmias occur within 2 minutes of administration and reverse shortly thereafter. Atropine should be available for immediate use in case of severe cholinergic reaction. Bradyarrhythmias respond to small doses of atropine.
• Nondepolarizing muscle relaxants: Should not be administered before any nondepolarizing muscle relaxant.
Dosage form specific issues:
• Sodium sulfite: Products may contain sodium sulfite.
Monitoring Parameters
Vital signs, ECG, and ventilatory support; neuromuscular function
Pregnancy Risk Factor
C
Pregnancy Considerations
Animal reproduction studies have not been conducted with this combination. Refer to individual agents.
Patient Education
• Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?)
• Patient may experience dry mouth, nausea, vomiting, diarrhea, abdominal cramps, loss of strength and energy, sweating a lot, or passing a lot of urine. Have patient report immediately to prescriber abnormal heartbeat, difficulty breathing, slow breathing, shallow breathing, severe dizziness, passing out, seizures, difficulty speaking, difficulty swallowing, slow heartbeat, fast heartbeat, or severe injection site redness, burning, or pain (HCAHPS).
• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.
Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients.
Further information
Medical Disclaimer
The content of Holevn is solely for the purpose of providing information about Thuốc Edrophonium and Atropine and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Please contact your nearest doctor or clinic, hospital for advice. We do not accept liability if the patient arbitrarily uses the drug without following a doctor’s prescription.
Reference from: https://www.drugs.com/ppa/edrophonium-and-atropine.html
• Atropine: Patients who are bradycardic or at risk of being bradycardic (eg, those on a beta-blocker or cardiovascular patients who received anesthesia with an opioid and nitrous oxide only) should first receive atropine prior to edrophonium-atropine combination. Most arrhythmias occur within 2 minutes of administration and reverse shortly thereafter. Atropine should be available for immediate use in case of severe cholinergic reaction. Bradyarrhythmias respond to small doses of atropine.
• Nondepolarizing muscle relaxants: Should not be administered before any nondepolarizing muscle relaxant.
Dosage form specific issues:
• Sodium sulfite: Products may contain sodium sulfite.
Monitoring Parameters
Vital signs, ECG, and ventilatory support; neuromuscular function
Pregnancy Risk Factor
C
Pregnancy Considerations
Animal reproduction studies have not been conducted with this combination. Refer to individual agents.
Patient Education
• Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?)
• Patient may experience dry mouth, nausea, vomiting, diarrhea, abdominal cramps, loss of strength and energy, sweating a lot, or passing a lot of urine. Have patient report immediately to prescriber abnormal heartbeat, difficulty breathing, slow breathing, shallow breathing, severe dizziness, passing out, seizures, difficulty speaking, difficulty swallowing, slow heartbeat, fast heartbeat, or severe injection site redness, burning, or pain (HCAHPS).
• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.
Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients.
Further information
Medical Disclaimer
The content of Holevn is solely for the purpose of providing information about Thuốc Edrophonium and Atropine and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Please contact your nearest doctor or clinic, hospital for advice. We do not accept liability if the patient arbitrarily uses the drug without following a doctor’s prescription.
Reference from: https://www.drugs.com/ppa/edrophonium-and-atropine.html
